Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?
  • Erika Poggiali
    Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy
  • Davide Bastoni
    Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy
  • Eva Ioannilli
    Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy
  • Andrea Vercelli
    Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy
  • Andrea Magnacavallo
    Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy

Keywords

COVID-19 pneumonia, deep vein thrombosis, venous thromboembolism, pulmonary embolism, heparin

Abstract

Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently declared a global health emergency by the WHO Emergency Committee. The most common symptoms are fever and cough, which can progress to pneumonia, acute respiratory distress syndrome (ARDS) and/or end-organ failure. Risk factors associated with ARDS and death are older age, comorbidities (e.g., hypertension, diabetes, hyperlipidaemia), neutrophilia, and organ and coagulation dysfunction. Disseminated intravascular coagulation and coagulopathy can contribute to death. Anticoagulant treatment is associated with decreased mortality in severe COVID-19 pneumonia. In this report we describe two patients with COVID-19 pneumonia who developed venous thromboembolism.

VIEW THE ENTIRE ARTICLE

References

  • Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus 133 in Wuhan, China. Lancet 2020;395(10223):497–506.

  • Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020 Mar 5. doi: 10.1038/s41569-020-0360-5. [Epub ahead of print]

  • Poggiali E, Dacrema A, Bastoni D, Tinelli V, Demichele E, Mateo Ramos P, et al. Can lung ultrasound help critical care clinicians in the early diagnosis of novel coronavirus (COVID-19) pneumonia? Radiology 2020 Mar 13:200847. doi: 10.1148/radiol.2020200847. [Epub ahead of print]

  • Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017;39(5):529–539.

  • Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020;20(4):400–402.

  • Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020 Mar 13. doi: 10.1001/jamainternmed.2020.0994. [Epub ahead of print]

  • Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open 2017;7(9):e017046.

  • Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020 Mar 27. doi: 10.1111/jth.14817. [Epub ahead of print]

  • Mackman N. Mouse models, risk factors, and treatments of venous thrombosis. Arterioscler Thromb Vasc Biol 2012;32:554–555.

    • Views: 5058
    HTML downloads: 432
    PDF downloads: 2540

    Published: 2020-04-08
    Issue: 2020: Vol 7 No 5 (view)

    How to cite:
    1.
    Poggiali E, Bastoni D, Ioannilli E, Vercelli A, Magnacavallo A. Deep Vein Thrombosis and Pulmonary Embolism: Two Complications of COVID-19 Pneumonia?. EJCRIM 2020;7 doi:10.12890/2020_001646.

    Most read articles by the same author(s)